ResearchPostmarket Drug Safety-Related Actions Before and After the US Food and Drug Administration Amendments Act
ResearchPremarket and Postmarket Real-World Evidence Studies Supporting US Food and Drug Administration Regulatory Decision-Making, 2016–2024
ResearchPolitics, Science, and the Future of FDA Drug Regulation: FDA's Review of Mifepristone REMS as a Litmus Test
ResearchFDA Approval of Benzgalantamine Exposes Flaws in the 505(b)(2) Pathway for Innovations on Existing Drugs
ResearchPharmaceutical Manufacturer Kickback Resolutions and Associated Financial Penalties, 2000–2025
ResearchUS Food and Drug Administration Sentinel Initiative and Postmarket Drug Safety Surveillance: A Review
ResearchEvidence Supporting European Medicines Agency Drug Approvals (2020–2023): A Cross-Sectional Study of Trial Design and Outcomes
ResearchIndustry Promotion of Oncology Drugs with Accelerated Approval That Failed Confirmatory Trials